Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 7/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.55 |
| ▸ | MME | P08473 | 2/20 | 0.52 |
| ▸ | NPY1R | P25929 | 1/20 | 0.49 |
| ▸ | NPY2R | P49146 | 1/20 | 0.49 |
| ▸ | NPY4R | P50391 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29459545 | 0.93 | OPRK1 (0.58) | OPRK1OPRM1MMENPY1RNPY2R | |
| SCHEMBL29808027 | 0.88 | GNPAT (0.58) | OPRK1OPRM1 | |
| SCHEMBL30073889 | 0.86 | BACE1 (0.48) | OPRK1OPRM1 | |
| SCHEMBL29380139 | 0.86 | GHSR (0.54) | OPRK1MME | |
| SCHEMBL30388715 | 0.86 | MME (0.56) | MME | |
| SCHEMBL2777114 | 0.86 | OPRK1 (0.59) | OPRK1NPY1RNPY2RNPY4R | |
| SCHEMBL2777118 | 0.86 | OPRK1 (0.59) | OPRK1NPY1RNPY2RNPY4R | |
| SCHEMBL31433322 | 0.85 | MME (0.62) | OPRM1MME | |
| SCHEMBL30957128 | 0.84 | OPRK1 (0.68) | OPRK1OPRM1NPY1RNPY2RNPY4R | |
| SCHEMBL31152919 | 0.84 | OPRK1 (0.63) | OPRK1OPRM1MMENPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514937-B2 | Methods for detecting CCR2 receptors | WASHINGTON UNIVERSITY (US) | 2026-01-06 | — | — | US | claimed |
| US-20240299598-A1 | METHODS FOR DETECTING CCR2 RECEPTORS | WASHINGTON UNIVERSITY (US) | 2024-09-12 | — | — | US | claimed |
| US-12016935-B2 | Methods for detecting CCR2 receptors | WASHINGTON UNIVERSITY (US) | 2024-06-25 | — | — | US | claimed |
| US-12514937-B2 | Methods for detecting CCR2 receptors | WASHINGTON UNIVERSITY (US) | 2026-01-06 | — | — | US | disclosed |
| US-20240299598-A1 | METHODS FOR DETECTING CCR2 RECEPTORS | WASHINGTON UNIVERSITY (US) | 2024-09-12 | — | — | US | disclosed |
| US-12016935-B2 | Methods for detecting CCR2 receptors | WASHINGTON UNIVERSITY (US) | 2024-06-25 | — | — | US | disclosed |
| US-20230381349-A1 | METHODS AND COMPOSITIONS FOR IMAGING AND TREATING CANCER | WASHINGTON UNIVERSITY (US) | 2023-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12016935-B2 | Methods for detecting CCR2 receptors | CCR2, CCR1, CCR5 | OPRK1 236/4885OPRM1 270/4885MME 1386/4885 |
| US-20240299598-A1 | METHODS FOR DETECTING CCR2 RECEPTORS | CCR2, CCR1, CCR5 | OPRK1 236/4885OPRM1 270/4885MME 1386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.